Truist lifts Regeneron price target to $780
Truist Securities raised its price target on Regeneron Pharma to $780.00 per share from $772.00, per Benzinga ratings coverage.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.